NCLT Hyderabad allows amalgamation of Eugia Steriles and Eugia SEZ into parent Eugia Pharma Specialities.
Tribunal dispenses with shareholder and most creditor meetings but orders separate meetings for unsecured creditors of transferor companies.
The scheme aims to consolidate sterile injectables business, simplify corporate structure, and achieve operational synergies.
Meetings for unsecured creditors with claims above ₹15L and ₹10L are scheduled for November 20, 2026.